Regenxbio
Price & Volume
Stats
See moreOpen | $10.13 |
Previous Close | $9.96 |
Day Range | $9.88-$10.43 |
52W Range | $5.45-$16.19 |
Market Cap | $620.3M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $87.8M |
Revenue Growth (YoY) | -92.8% |
Gross Profit (12 Mos) | -$172.6M |
Diluted EPS | -$5.60 |
News
See moreYahoo Finance • 17 days ago
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Yahoo Finance • 18 days ago
REGENXBIO Prices $100M Public Offering To Advance Gene Therapy Programs; Stock Down
Yahoo Finance • 18 days ago
Netflix, Intuitive Surgical tumble premarket
Yahoo Finance • 18 days ago
REGENXBIO stock dips on $100M equity offering
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 371 |